FDA’s activities in the Asia and Pacific region include engaging with foreign regulatory counterparts on all products over which FDA has regulatory responsibility. This includes managing the sharing of non-public information and addressing regulatory compliance issues, some of which have a global impact. FDA’s activities and sharing of technical expertise with its foreign regulatory counterparts enhances a country’s ability to produce safe and effective foods and medical products and provide exports that meet the FDA standard. Information sharing and capacity building activities help the foreign country to enhance its regulatory infrastructure, safeguard the health of its citizens and contribute to global health. Coordination of technical assistance that results from specific arrangements with countries in Asia and the Pacific are also a part of FDA’s activities and they include regional economic communities such as the Association of Southeast Asian Nations (ASEAN) and bilateral activities with Canada, Japan, Australia, New Zealand and Singapore, international conferences, and important training regarding clinical trials, pharmacovigilance, seafood safety, medical device reviews, drug approvals, and risk communications. FDA’s strengthening of regulatory systems in these regions allows it to fulfill its mandate of consumer protection for Americans.